[Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient]

Arch Pediatr. 2006 Dec;13(12):1556-7. doi: 10.1016/j.arcped.2006.09.009. Epub 2006 Oct 16.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amphotericin B / administration & dosage
  • Amphotericin B / pharmacology*
  • Amphotericin B / therapeutic use
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use*
  • Brain Neoplasms / therapy
  • Candida / drug effects*
  • Candida albicans / drug effects
  • Candida glabrata / drug effects
  • Candidiasis / complications
  • Candidiasis / drug therapy*
  • Caspofungin
  • Child, Preschool
  • Drug Resistance, Fungal / drug effects*
  • Echinocandins
  • Humans
  • Immunocompromised Host*
  • Lipopeptides
  • Male
  • Neuroectodermal Tumors / therapy
  • Neutropenia / complications*
  • Peptides, Cyclic / administration & dosage
  • Peptides, Cyclic / pharmacology
  • Peptides, Cyclic / therapeutic use*
  • Time Factors

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides, Cyclic
  • liposomal amphotericin B
  • Amphotericin B
  • Caspofungin